{"organizations": [], "uuid": "df11c360de1e532e769b12a27fcdba37f4713ab1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/5", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/22/globe-newswire-geron-announces-conference-call-to-discuss-fourth-quarter-and-annual-2017-financial-results.html", "country": "US", "domain_rank": 767, "title": "Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2017 Financial Results", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-23T00:05:00.000+02:00", "replies_count": 0, "uuid": "df11c360de1e532e769b12a27fcdba37f4713ab1"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/22/globe-newswire-geron-announces-conference-call-to-discuss-fourth-quarter-and-annual-2017-financial-results.html", "ord_in_thread": 0, "title": "Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2017 Financial Results", "locations": [], "entities": {"persons": [{"name": "geron geron", "sentiment": "none"}], "locations": [{"name": "menlo park", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "geron", "sentiment": "negative"}, {"name": "geron corporation", "sentiment": "negative"}, {"name": "eastern time", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "MENLO PARK, Calif., Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2017, on Friday, March 16, 2018, after the market close. Geron’s management will also host a conference call for analysts and investors on Monday, March 19, 2018, at 8:30 a.m. Eastern Time to discuss the company’s fourth quarter and annual results as well as recent events.\nParticipants can access the conference call live via telephone by dialing 877-303-9139 (U.S.); 760-536-5195 (international). The conference ID is 3564078. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available through the Investors section of our website at www.geron.com or at https://edge.media-server.com/m6/p/4hrpsmd2 . The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through April 20, 2018.\nAbout Geron\nGeron is a biopharmaceutical company supporting the clinical stage development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com .\nCONTACT:\nAnna Krassowska, Ph.D.\nInvestor and Media Relations\n650-473-7765\ninvestor@geron.com\nmedia@geron.com\nSource:Geron Corporation", "external_links": ["https://www.globenewswire.com/NewsRoom/AttachmentNg/58094c6f-e665-402d-a7c0-f39da205b99c", "https://edge.media-server.com/m6/p/4hrpsmd2"], "published": "2018-02-23T00:05:00.000+02:00", "crawled": "2018-02-22T23:57:09.001+02:00", "highlightTitle": ""}